Heidi Cuthbert

Nexalis Therapeutics (ASX:NX1) announced a clinical breakthrough with the screening of the first patient in its Phase 2 clinical trial for IRX-211.

True North Copper (ASX:TNC) to acquire Renegade Exploration’s (ASX:RNX) 22% interest in the Carpentaria JV.

The Australian Securities Exchange (ASX:ASX) launched the first phase of its long-awaited CHESS replacement on April 20.

Fletcher Building (ASX:FBU) received final regulatory approvals for the sale of its construction division to VINCI Construction.

Tyler Technologies (NYSE:TYL) announced today the completion of its acquisition of For The Record, a prominent provider of digital court-recording and transcription technology.

Pfizer (NYSE:PFE) and Astellas announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for the perioperative use of Padcev (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab).

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from its pivotal Phase III MIRANDA trial, evaluating tozorakimab as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Genprex (NASDAQ:GNPX), a clinical-stage gene therapy company, announced today that its collaborators presented compelling preclinical data for its lead drug candidate, Reqorsa® (quaratusugene ozeplasmid), at the American Association for Cancer Research (AACR) Annual Meeting 2026.

Solidion Technology (NASDAQ:STI), an advanced battery materials provider, has finalized a binding strategic patent monetization agreement with Hilco Global’s IP Services Practice.

Cleveland-Cliffs (NYSE:CLF), the largest flat-rolled steel producer in North America, reported a significant sequential increase in operational volume and revenue for the first quarter ended March 31, 2026.